Transgene Biotek incorporates wholly owned subsidiary company

24 Dec 2020 Evaluate

Transgene Biotek has incorporated a wholly owned subsidiary company namely 'Peroral Bio' on December 23, 2020. The company has incorporated a wholly owned subsidiary company for carrying out the business of Pharmaceutical and biotechnology related operations and formulations.

Transgene Biotek (TBL) is engaged in manufacturing drugs for:New Drug Delivery System (NDDS)-Oral Delivery of Insulin,Oral Delivery Hepatitis B Vaccine and Pegylation of Protein Drugs.

Transgene Biotek Share Price

2.26 0.13 (6.10%)
02-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 6933.65
Max Healthcare Inst 958.45
Narayana Hrudayalay 1763.85
Aster DM Healthcare 556.95
Global Health 1140.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×